Table 1

Clinical and demographic features of the studied subjects
Characteristics SLE patients Healthy controls
Pre-treatment Post-treatment
No. of cases 40 40 40
Female, n (%) 36 (90.0%) 36 (90.0%) 36 (90.0%)
Male, n (%) 4 (10%) 4 (10%) 4 (10%)
Age, years (range) 33.7 (20 ~ 55) 33.7 (20 ~ 55) 34.8 (21 ~ 57)
Course of disease months 11.2 (1 ~ 26) 12.2 (2 ~ 27) -
(range)
SLEDAI (mean ± SD) 11.45 ± 3.76 7.90 ± 4.00 -
Skin and mucosa lesion 28 (70.0%) 15 (37.5%0) -
Serositis, n (%) 15 (37.5%) 8 (20.0%) -
Arthritis, n (%) 18 (45.0%) 4 (10.0%) -
Lupus nephritis, n (%) 24 (60.0%) 20 (50%) -
Hematologic involvement 25 (62.5%) 9 (22.5%) -
NPSLE, n (%) 1 (2.5%) 0 -
ANA, n (%) 40 (100%) 39 (97.5%) 0
Anti-dsDNA antibody, (%) 18 (45.0%) 14 (35.0%) 0

Song et al.

Song et al. Diagnostic Pathology 2013 8:175   doi:10.1186/1746-1596-8-175

Open Data